ASX - By Stock
|
RGT |
Re:
Ann: Results from ArtemiC Safety and Toxicity Pre-clinical Study
|
|
Fiscal 1
|
3 |
2.0K |
2 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
3
|
2.0K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
Fiscal 1
|
94 |
37K |
3 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
94
|
37K
|
3
|
|
ASX - By Stock
|
BPT |
Re:
Ann: Business Update
|
|
Fiscal 1
|
537 |
173K |
3 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
537
|
173K
|
3
|
|
ASX - By Stock
|
BPT |
Re:
Ann: Quarterly report for the period ended 31 March 2020
|
|
Fiscal 1
|
11 |
4.5K |
1 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
11
|
4.5K
|
1
|
|
ASX - By Stock
|
BPT |
Re:
Ann: Business Update
|
|
Fiscal 1
|
537 |
173K |
3 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
537
|
173K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Voluntary Suspension Extension
|
|
Fiscal 1
|
18 |
7.7K |
2 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
18
|
7.7K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Voluntary Suspension Extension
|
|
Fiscal 1
|
28 |
10K |
2 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
28
|
10K
|
2
|
|
ASX - By Stock
|
BPT |
Re:
Ann: Business Update
|
|
Fiscal 1
|
537 |
173K |
3 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
537
|
173K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Voluntary Suspension Extension
|
|
Fiscal 1
|
77 |
25K |
24 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
77
|
25K
|
24
|
|
ASX - By Stock
|
NAB |
Re:
NAB - Market Melt Down
|
|
Fiscal 1
|
134 |
60K |
2 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
134
|
60K
|
2
|
|
ASX - By Stock
|
NAB |
Re:
NAB Target Price $34 by June 2020
|
|
Fiscal 1
|
759 |
372K |
2 |
14/03/20 |
14/03/20 |
ASX - By Stock
|
759
|
372K
|
2
|
|
ASX - By Stock
|
NAB |
Re:
NAB new target $14 to $15
|
|
Fiscal 1
|
30 |
13K |
2 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
30
|
13K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Extension of SPP Closing Date
|
|
Fiscal 1
|
62 |
22K |
6 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
62
|
22K
|
6
|
|
ASX - By Stock
|
RGT |
Re:
Should be renamed Coles
|
|
Fiscal 1
|
6 |
2.5K |
3 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
6
|
2.5K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Patients Begin Treatment in Clinical Trial of CogniCann
|
|
Fiscal 1
|
29 |
10K |
3 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
29
|
10K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Patients Begin Treatment in Clinical Trial of CogniCann
|
|
Fiscal 1
|
29 |
10K |
4 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
29
|
10K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Binding Amendment to Supply Agreement with ONIX Brazil
|
|
Fiscal 1
|
44 |
33K |
9 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
44
|
33K
|
9
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
Fiscal 1
|
28 |
821K |
1 |
02/03/20 |
02/03/20 |
ASX - By Stock
|
28
|
821K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
Fiscal 1
|
111 |
97K |
4 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
111
|
97K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Buy zone
|
|
Fiscal 1
|
61 |
30K |
2 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
61
|
30K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: THC: Product Supply Agreement Signed with MGC Pharma
|
|
Fiscal 1
|
46 |
22K |
8 |
21/01/20 |
21/01/20 |
ASX - By Stock
|
46
|
22K
|
8
|
|
ASX - By Stock
|
RGT |
Calls for PBS
|
|
Fiscal 1
|
3 |
3.4K |
18 |
14/10/19 |
14/10/19 |
ASX - By Stock
|
3
|
3.4K
|
18
|
|
ASX - By Stock
|
RGT |
Re:
It's just a matter of time...
|
|
Fiscal 1
|
172 |
59K |
8 |
10/10/19 |
10/10/19 |
ASX - By Stock
|
172
|
59K
|
8
|
|
ASX - By Stock
|
RGT |
Re:
It's just a matter of time...
|
|
Fiscal 1
|
172 |
59K |
3 |
10/10/19 |
10/10/19 |
ASX - By Stock
|
172
|
59K
|
3
|
|
ASX - By Stock
|
RGT |
Dementia
|
|
Fiscal 1
|
2 |
2.3K |
7 |
09/10/19 |
09/10/19 |
ASX - By Stock
|
2
|
2.3K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma Passes 400 Prescription Milestone in September
|
|
Fiscal 1
|
104 |
33K |
1 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
104
|
33K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma Passes 400 Prescription Milestone in September
|
|
Fiscal 1
|
104 |
33K |
0 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
104
|
33K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma Passes 400 Prescription Milestone in September
|
|
Fiscal 1
|
104 |
33K |
4 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
104
|
33K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
When retailers meet Roby...
|
|
Fiscal 1
|
35 |
14K |
7 |
09/09/19 |
09/09/19 |
ASX - By Stock
|
35
|
14K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
When retailers meet Roby...
|
|
Fiscal 1
|
35 |
14K |
6 |
09/09/19 |
09/09/19 |
ASX - By Stock
|
35
|
14K
|
6
|
|
ASX - By Stock
|
RGT |
Re:
When retailers meet Roby...
|
|
Fiscal 1
|
35 |
14K |
6 |
09/09/19 |
09/09/19 |
ASX - By Stock
|
35
|
14K
|
6
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Epilepsy Clinical Study Comparing CannEpil to 100% CBD
|
|
Fiscal 1
|
71 |
33K |
2 |
04/09/19 |
04/09/19 |
ASX - By Stock
|
71
|
33K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Canaccord to Lead LSE Listing and $4.75m Placement Closed
|
|
Fiscal 1
|
139 |
60K |
1 |
25/08/19 |
25/08/19 |
ASX - By Stock
|
139
|
60K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Canaccord to Lead LSE Listing and $4.75m Placement Closed
|
|
Fiscal 1
|
139 |
60K |
1 |
25/08/19 |
25/08/19 |
ASX - By Stock
|
139
|
60K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
knock knock
|
|
Fiscal 1
|
1.0K |
701K |
0 |
19/08/19 |
19/08/19 |
ASX - By Stock
|
1.0K
|
701K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: YuShop Completes Chinese Market Test, Sales to Commence
|
|
Fiscal 1
|
33 |
15K |
7 |
07/08/19 |
07/08/19 |
ASX - By Stock
|
33
|
15K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ross Smith...
|
|
Fiscal 1
|
58 |
26K |
3 |
28/07/19 |
28/07/19 |
ASX - By Stock
|
58
|
26K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ross Smith...
|
|
Fiscal 1
|
58 |
26K |
3 |
28/07/19 |
28/07/19 |
ASX - By Stock
|
58
|
26K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
CBD research
|
|
Fiscal 1
|
2 |
1.1K |
0 |
08/07/19 |
08/07/19 |
ASX - By Stock
|
2
|
1.1K
|
0
|
|
ASX - By Stock
|
RGT |
CBD research
|
|
Fiscal 1
|
2 |
1.1K |
0 |
08/07/19 |
08/07/19 |
ASX - By Stock
|
2
|
1.1K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Share price by Xmas 2019
|
|
Fiscal 1
|
44 |
18K |
3 |
11/06/19 |
11/06/19 |
ASX - By Stock
|
44
|
18K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Share price by Xmas 2019
|
|
Fiscal 1
|
44 |
18K |
1 |
10/06/19 |
10/06/19 |
ASX - By Stock
|
44
|
18K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: New Distribution Agreements Signed for CannEpil & IMP's
|
|
Fiscal 1
|
67 |
26K |
13 |
02/05/19 |
02/05/19 |
ASX - By Stock
|
67
|
26K
|
13
|
|
ASX - By Stock
|
RGT |
Re:
Mxc-social media
|
|
Fiscal 1
|
667 |
373K |
0 |
30/04/19 |
30/04/19 |
ASX - By Stock
|
667
|
373K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
MXC valued at A$0.11 per share based on Edison Investment Research.
|
|
Fiscal 1
|
48 |
26K |
10 |
23/04/19 |
23/04/19 |
ASX - By Stock
|
48
|
26K
|
10
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Received CannEpil Purchase Orders and Import Permit for UK
|
|
Fiscal 1
|
90 |
37K |
2 |
12/04/19 |
12/04/19 |
ASX - By Stock
|
90
|
37K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Cannepil price
|
|
Fiscal 1
|
102 |
27K |
4 |
28/03/19 |
28/03/19 |
ASX - By Stock
|
102
|
27K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Fiscal 1
|
60 |
23K |
0 |
11/03/19 |
11/03/19 |
ASX - By Stock
|
60
|
23K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Expiration of 100m Performance Shares
|
|
Fiscal 1
|
32 |
15K |
2 |
08/03/19 |
08/03/19 |
ASX - By Stock
|
32
|
15K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
knock knock
|
|
Fiscal 1
|
1.0K |
701K |
2 |
06/03/19 |
06/03/19 |
ASX - By Stock
|
1.0K
|
701K
|
2
|
|